Section 5(a)(1) of the Occupational Safety and Health Act of 1970: The employer did not furnish employment and a place of employment which were free from recognized hazards that were causing or likely to cause death or serious physical harm to employees in that employees were exposed to the hazard of exposure to cytotoxic/antineoplastic/chemotherapy drugs: a)The employer did not ensure that employees working with cytotoxic drugs(chemotherapy drugs) such as, but not limited to L-asparginase, carboplatin, cyclophosphamide, cytarrabine, daunorubicin, doxorubicin, etoposide, fluorouracil, ganciclovir, hydroxyurea, ifosfamide, medroxyprogestrone, mercaptopurine, methotrexate, tamoxifin, thioguanine, vinblastine, vincristine, and zidovudine were trained in proper handling procedures and/or spill procedures, work practice controls, engineering controls, and personal protective equipment. b)Employees were not included in a medical surveillance program to include pre-placement medical exams, periodic exams, postexposure examinations, and exit exams. Among other methods, one feasible and acceptable abatement to correct this hazard is to develop a written hazardous drug safety and health plan by following the American Society of Hospital Pharmacist Technical Assistance Bulletin.e